| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 2041075-86-7 | AZD 5718) | AZD5718 AZD 5718) Atuliflapon Cyclohexanecarboxamide, 2-[4-(5-methyl-1H-pyrazol-3-yl)benzoyl]-N-(4,5,6,7-tetrahydro-4-oxopyrazolo[1,5-a]pyrazin-3-yl)-, (1R,2R)- | ||
| 2 | 1220699-06-8 | PF-04979064 | CS-2664 PF04979064 PF 04979064 PF-04979064 (S)-1-(1-(2-hydroxypropanoyl)piperidin-4-yl)-3-methyl-8-(6-methylpyridin-3-yl)-1H-imidazo[4,5-c][1,5]naphthyridin-2(3H)-one 1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-imidazo[4,5-c][1,5]naphthyridin-2-one 2H-Imidazo[4,5-c][1,5]naphthyridin-2-one, 1,3-dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)- | ||
| 3 | 918870-43-6 | Lck Inhibitor II | Lck Inhibitor II LCK INHIBITOR II | ||
| 4 | 1505484-77-4 | Daridorexant Impurity 61 | Impurities 61 in Nemoreson | ||
| 5 | 2412144-74-0 | Propanamide, N-[6-[3,4-dihydro-3-[2-(4-morpholinyl)ethyl]-4-oxo-6-quinazolinyl]-1H-benzimidazol-2-yl]- | Propanamide, N-[6-[3,4-dihydro-3-[2-(4-morpholinyl)ethyl]-4-oxo-6-quinazolinyl]-1H-benzimidazol-2-yl]- | ||
| 6 | 144689-24-7 | 4-(2-Hydroxy-2-propanyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid | CS 088 CS-415 Olmesartan Olmesartan Acid Olmesartan Medoxomil-1 Olmesartan (Olmesartan Medoxomil EP Impurity A) 4-(2-Hydroxy-2-propanyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid 1H-Imidazole-5-carboxylicacid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | ||
| 7 | 797814-82-5 | 1-(3-ethoxypropyl)-2-imino-10-methyl-5-oxo-N-(pyridin-3-ylmethyl)dipyrido[3,4-c:1',2'-f]pyrimidine-3-carboxamide | 1-(3-ethoxypropyl)-2-imino-10-methyl-5-oxo-N-(pyridin-3-ylmethyl)dipyrido[3,4-c:1',2'-f]pyrimidine-3-carboxamide 2H-Dipyrido[1,2-a:2',3'-d]pyrimidine-3-carboxamide, 1-(3-ethoxypropyl)-1,5-dihydro-2-imino-10-methyl-5-oxo-N-(3-pyridinylmethyl)- BAS 04996160 | ||
| 8 | 4-MORPHOLIN-4-YL-2-PYRIDIN-4-YL-7,8-DIHYDRO-5H-PYRIDO[4,3-D]PYRIMIDINE-6-CARBOXYLIC ACID (3-METHOXY-PHENYL)-AMIDE | 4-MORPHOLIN-4-YL-2-PYRIDIN-4-YL-7,8-DIHYDRO-5H-PYRIDO[4,3-D]PYRIMIDINE-6-CARBOXYLIC ACID (3-METHOXY-PHENYL)-AMIDE | |||
| 9 | 4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid | 4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid | |||
| 10 | 1448169-77-4 | 2-Propen-1-one, 1-[(3S)-3-[4-amino-3-[2-(3,5-diethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]- | 2-Propen-1-one, 1-[(3S)-3-[4-amino-3-[2-(3,5-diethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]- Bexagliflozin Impurity 22 Futibatinib Impurity 8 |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|